Evidence map›Paper›PMID 24698079›Full record

ArticleDrug and alcohol dependence2014

Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States.

Irene Kuo, Carol E Golin, Jing Wang, Danielle F Haley, James Hughes, Sharon Mannheimer, Jessica Justman, Anne Rompalo, Paula M Frew, Adaora A Adimora and 3 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Drug and alcohol dependence, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00995176 (The Women's HIV SeroIncidence Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00995176 completednot on this map

The Women's HIV SeroIncidence Study (ISIS)

TypeobservationalSponsorHIV Prevention Trials NetworkRan2009 to 2011Enrolled2,099ConditionsHIV Infections
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Are you thinking what I'm thinking? Defining what we mean by "polysubstance use."The American journal of drug and alcohol abuse · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Irene KuoGeorge Washington University, School of Public Health and Health Services, Washington, DC, USA. Electronic address: ikuo@gwu.edu.
Carol E GolinUniversity of North Carolina School of Medicine and Gillings School of Global Public Health, Chapel Hill, NC, USA.
Jing WangFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Danielle F HaleyFHI 360, Durham, NC, USA; Rollins School of Public Health, Department of Behavioral Sciences and Health Education, Atlanta, GA, USA.
James HughesFred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA.
Sharon MannheimerHarlem Hospital Center, New York, NY, USA; Mailman School of Public Health, Columbia University, New York, NY, USA.
Jessica JustmanMailman School of Public Health, Columbia University, New York, NY, USA.
Anne RompaloJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Paula M FrewRollins School of Public Health, Department of Behavioral Sciences and Health Education, Atlanta, GA, USA; Emory University, Department of Medicine, Division of Infectious Diseases, Atlanta, GA, USA.
Adaora A AdimoraUniversity of North Carolina School of Medicine and Gillings School of Global Public Health, Chapel Hill, NC, USA.
Lydia Soto-TorresNational Institutes of Health, National Institute on Allergy and Infectious Diseases, Bethesda, MD, USA.
Sally HodderRutgers, New Jersey Medical School, Newark, NJ, USA.
HPTN 064 Study Team
Columbia University · USUniversity of North Carolina at Chapel Hill · USEmory University · USFred Hutch Cancer Center · USGeorge Washington University · USGeorgia Department of Public Health · USJohns Hopkins University · USNational Institute of Allergy and Infectious Diseases · USRutgers, The State University of New Jersey · USUniversity of Washington · US

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI MYRON Scott COHEN, Sinead Delany-Moretlwe · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
HIV Prevention trials Network (HPTN) Coordinating and Operations CenterU01AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI VERMUND, STEN H. · 2006 to 2010
$72.7M
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit 2024 SupplementUM1AI069423 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, MINA CHRISTINE HOSSEINIPOUR · 2012 to 2026
$71.8M
Emory HIV/AIDS Clinical Trials UnitUM1AI069418 · NIAID · EMORY UNIVERSITY · PI Colleen F Kelley · 2012 to 2026
$46.0M
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials UnitUM1AI069419 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 2012 to 2026
$44.6M
NCATS NIH HHS UL1 TR000454NCRR NIH HHS RR025747NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1 RR025008NCRR NIH HHS UL1RR025008NCRR NIH HHS UL1 RR025747NCRR NIH HHS UL1 RR25005NIAID NIH HHS 5UM1AI069503-07NIAID NIH HHS 5UO1AI069418NIAID NIH HHS AI050410NIAID NIH HHS AI069423NIAID NIH HHS (AI069465NIAID NIH HHS P30 AI050409NIAID NIH HHS P30AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI087714NIAID NIH HHS U01 AI068613NIAID NIH HHS U01-AI068613NIAID NIH HHS U01 AI068619NIAID NIH HHS U01 AI069418NIAID NIH HHS U01 AI069423NIAID NIH HHS U01 AI069465NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1-AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1AI068619NIAID NIH HHS UM1 AI069418NIAID NIH HHS UM1 AI069419NIAID NIH HHS UM1 AI069423NIAID NIH HHS UM1 AI069465NIAID NIH HHS UM1 AI069470NIAID NIH HHS UM1 AI069503NICHD NIH HHS K24 HD069204NIGMS NIH HHS U54 GM104942PHS HHS 5U1AL069466
6 · The paper itself

Abstract

backgroundSubstance use is associated with HIV sexual risk behaviors, yet few studies have examined substance use patterns longitudinally. We evaluated the types and frequency of substances used over a six-month period among U.S. women at risk for HIV acquisition.

methodsWomen reporting unprotected sex with a man in the previous six months and at least one other personal or partner HIV risk characteristic enrolled in a multisite cohort study and completed interviews about substance use at study visits. Prevalence and frequency of substance use at the baseline and six-month visits were compared and correlates of decreased substance use at the six-month visit were assessed.

resultsOf 2099 women enrolled, 1882 had substance use data at baseline and six-months. Of these, 76.1% reported using at least one drug or binge drinking in the previous six months; 37.5% were frequent and 38.6% non-frequent substance users. Binge drinking was most frequently reported (63.3%), followed by cocaine (25.0%) and opioids (16.5%). Fifty-five percent of opiate users and 30% of cocaine users reported daily/almost daily use. At the six-month visit, 40.5% reported a decrease in frequency of use. Adjusting for income and type of drug used, poly-substance users were less likely to decrease frequency of use compared to those who only used one substance.

conclusionA substantial decrease in frequency of substance use over time was observed in this cohort. Poly-substance users were less likely to reduce frequency of use over time, suggesting that specific substance use interventions targeting these users are warranted.

Indexed as

AdolescentAdultBinge DrinkingCocaine-Related DisordersFemaleHIV InfectionsHumansInterviews as TopicLongitudinal StudiesOpioid-Related DisordersPrevalenceRisk FactorsSubstance-Related DisordersUnited StatesUnsafe SexYoung AdultBinge drinkingCocaine useHIVOpiate useSubstance useWomen

Identifiers

PMID24698079
PMCPMC4104540
OpenAlexW1979951621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.